This company has been acquired
The company may no longer be operating, as it has been acquired. Find out why through their latest events.
Jounce Therapeutics Management
Management criteria checks 2/4
Key information
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | n/a |
| Management average tenure | 11.3yrs |
| Board average tenure | 6.3yrs |
Recent management updates
Recent updates
We're A Little Worried About Jounce Therapeutics' (NASDAQ:JNCE) Cash Burn Rate
Jan 04
Here's Why We're Watching Jounce Therapeutics' (NASDAQ:JNCE) Cash Burn Situation
Sep 20Here's Why We're A Bit Worried About Jounce Therapeutics' (NASDAQ:JNCE) Cash Burn Situation
Jun 16We Think Jounce Therapeutics (NASDAQ:JNCE) Can Easily Afford To Drive Business Growth
Feb 23Jounce Therapeutics: A Favorable Risk-Reward Ahead Of Critical 2022 Catalysts
Dec 16News Flash: Analysts Just Made A Dazzling Upgrade To Their Jounce Therapeutics, Inc. (NASDAQ:JNCE) Forecasts
Aug 07Jounce Therapeutics: An Under The Radar And Undervalued Biotech
Jul 13Need To Know: Analysts Are Much More Bullish On Jounce Therapeutics, Inc. (NASDAQ:JNCE) Revenues
Jun 16Shareholders May Not Be So Generous With Jounce Therapeutics, Inc.'s (NASDAQ:JNCE) CEO Compensation And Here's Why
Jun 12Jounce Therapeutics EPS beats by $0.01, misses on revenue
May 04We're Hopeful That Jounce Therapeutics (NASDAQ:JNCE) Will Use Its Cash Wisely
May 03Jounce Therapeutics (NASDAQ:JNCE) Shareholders Have Enjoyed An Impressive 163% Share Price Gain
Mar 02News Flash: Analysts Just Made A Sizeable Upgrade To Their Jounce Therapeutics, Inc. (NASDAQ:JNCE) Forecasts
Mar 02Enrollment underway in Jounce Therapeutics' early-stage JTX-8064 study in solid tumors
Jan 13Have Insiders Sold Jounce Therapeutics, Inc. (NASDAQ:JNCE) Shares Recently?
Jan 13
Jounce Therapeutics: A Potential Roller Coaster
Dec 31A Look At Jounce Therapeutics' (NASDAQ:JNCE) CEO Remuneration
Dec 15CEO
Jounce Therapeutics has no CEO, or we have no data on them.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 10.3yrs | US$980.58k | 0.13% $ 124.1k | |
| Founder | 11.3yrs | no data | no data | |
| Founder | 11.3yrs | no data | no data | |
| Founder | no data | no data | no data | |
| Founder | 11.3yrs | no data | no data | |
| Founder | 11.3yrs | no data | no data | |
| Founder | 11.3yrs | no data | no data | |
| Head of Investor Relations & Strategic Finance | no data | no data | no data | |
| Vice President of Investor Relations | no data | no data | no data | |
| Head of Business Development & Alliance Management | no data | no data | no data |
11.3yrs
Average Tenure
Experienced Management: JNCE's management team is seasoned and experienced (11.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Director | 7.3yrs | US$115.11k | 0.0095% $ 9.4k | |
| Independent Director | 7yrs | US$99.61k | 0% $ 0 | |
| Director | 8.8yrs | US$2.44m | 0.36% $ 354.9k | |
| Independent Director | 10.3yrs | US$84.61k | 0.18% $ 178.3k | |
| Independent Chairman | 1.7yrs | US$110.60k | 0% $ 0 | |
| Independent Director | 5.6yrs | US$84.61k | 0% $ 0 | |
| Independent Director | 3.3yrs | US$91.11k | 0% $ 0 | |
| Independent Director | 2.3yrs | US$88.45k | 0% $ 0 |
6.3yrs
Average Tenure
58yo
Average Age
Experienced Board: JNCE's board of directors are considered experienced (6.3 years average tenure).